The research advances produced by the Department of Genetics and Genomic Sciences are routinely featured in the news, research publications, and other media.
Our faculty is frequently featured in the news and in other academic publications.
Stat News: Inga Peter, wrote an opinion piece for Stat News about viral repurposing and how it can speed up the discovery of new uses for existing drugs. (1.12.19) Full story.
VOA Turkey: Zeynep H. Gümüş, interviewed with Voice of America to discuss her recent study on Fanconi Anemia germline mutations that increase the risk for squamous lung cancer. (1.9.19) Full story.
Stat News: Bruce Gelb, weighs in on the usefulness of a study where AI can detect genetic mutations through a photograph. (1.7.19) Full story.
GenomeWeb: Harm Van Bakel, spoke with GenomeWeb about the growing practice of hospitals sequencing pathogens isolated from patients who have either developed an antibiotic resistance or whose infections are suspected to be part of an outbreak. (11.15.18) Full story.
DDNews: Jun Zhu, spoke with Drug Discovery News about the predictive modeling system he and a team of researchers designed to infer the relationships between genes, drugs, and their environment over time. (11.13.18) Full story
We publish our own press releases highlighting the work of our accomplished faculty and staff.
Mount Sinai and USC Researchers Develop Prostate Cancer Prediction Tool That Has Unmatched Accuracy
February 7, 2019 - A team of researchers from the Icahn School of Medicine at Mount Sinai and Keck School of Medicine at the University of Southern California (USC) have developed a novel machine-learning framework that distinguishes between low- and high-risk prostate cancer.
Mount Sinai Partners with Paradigm Biopharmaceuticals Ltd. and ReqMed Company, Ltd. to Repurpose Drug to Battle Rare MPS Diseases
January 18, 2019 - The Icahn School of Medicine at Mount Sinai has entered into two exclusive licenses to develop the drug pentosan polysulfate sodium for the treatment of mucopolysaccharidosis (MPS), with Australia-based company Paradigm Biopharmaceuticals Ltd. (ASX: PAR) and ReqMed Company, Ltd. of Japan.
Researchers Discover That Kidney Disease Gene Affects More Populations Than Previously Thought
December 27, 2018 - In the largest population genomics investigation to date, a team of researchers at the Icahn School of Medicine at Mount Sinai, Stanford University, and the University of Colorado have discovered that kidney disease risk variants of the gene APOL1, previously known to affect African and African American populations, are also found at appreciable frequencies in Caribbean and Latin American populations.
Mount Sinai Researchers Use "Blacklist" Computing Concept as Novel Method to Streamline Genetic Analysis
December 24, 2018 - Researchers at the Icahn School of Medicine at Mount Sinai and The Rockefeller University have discovered a new use for a long-standing computational concept known as “blacklisting."
Sanofi, Sema4, Mount Sinai Collaborate on Largest Asthma Study of Its Kind
December 4, 2018 - Sema4, a patient-centered predictive health company, and the Mount Sinai Health System today announced the launch of a five-year collaborative study with Sanofi designed to provide new insights into the biological mechanisms and other factors implicated in asthma.